Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$4.91
-5.0%
$4.77
$3.42
$6.91
$305.98M1.912.04 million shs1.29 million shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$2.53
+1.2%
$2.23
$1.60
$2.77
$957.60M1.134.02 million shs3.95 million shs
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$6.47
+0.3%
C$6.21
C$5.09
C$6.55
C$644.76M0.19054866,047 shs27,763 shs
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
$16.60
$16.60
$14.90
$25.40
$141.07M1.7115,071 shsN/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-5.03%-7.88%+6.28%-9.24%-15.92%
Cronos Group Inc. stock logo
CRON
Cronos Group
+1.20%-1.17%+25.25%+32.46%+12.95%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
+0.31%-0.31%+4.86%+7.48%+18.07%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.2625 of 5 stars
0.01.00.00.02.20.80.6
Cronos Group Inc. stock logo
CRON
Cronos Group
1.8807 of 5 stars
0.03.00.00.03.10.02.5
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
1.2686 of 5 stars
2.70.00.00.01.21.70.6
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.00
BuyN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
0.00
N/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
3.33
BuyC$7.1510.51% Upside
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
2.58
Moderate Buy$16.60N/A

Current Analyst Ratings Breakdown

Latest ACB, THCX, CRON, and GUD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/8/2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell
(Data available from 9/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$246.72M1.12$0.55 per share8.87$7.54 per share0.65
Cronos Group Inc. stock logo
CRON
Cronos Group
$130.28M7.44N/AN/A$2.95 per share0.86
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$384.56M1.68C$1.68 per share3.85C$7.65 per share0.85
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$1.63M-$0.19N/A11.16N/A-5.66%-1.49%-1.06%11/5/2025 (Estimated)
Cronos Group Inc. stock logo
CRON
Cronos Group
$41.08M$0.0550.6084.33N/A14.19%-3.78%-3.62%11/11/2025 (Estimated)
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-C$30.73MN/AN/AN/A-8.81%-4.04%0.51%N/A
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/A0.00N/AN/AN/AN/AN/A

Latest ACB, THCX, CRON, and GUD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Cronos Group Inc. stock logo
CRON
Cronos Group
-$0.02-$0.10-$0.08-$0.10$45.73 million$33.46 million
8/6/2025Q1 2026
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.18-$0.19-$0.37-$0.20$96.83 million$71.98 million
6/18/2025Q4 2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.11$0.07-$0.04-$0.24$88.85 million$63.34 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AN/AN/AN/AN/A
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
$0.724.34%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.06
2.97
1.51
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
24.65
23.53
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
7.52
3.36
1.79
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
15.71%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Cronos Group Inc. stock logo
CRON
Cronos Group
7.30%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
45.62%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,13056.45 million56.45 millionOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
450383.04 million356.61 millionOptionable
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
72599.65 millionN/ANot Optionable
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A8.50 millionN/ANot Optionable

Recent News About These Companies

Trump's Cannabis Reforms Could Hand Altria A Fortune
Cannabis REIT IIPR Trades At A Very Low Valuation
WM Technology Is A Good Stock For Cannabis Investors
Aurora Cannabis: Poised For Its First Profitable Year
Aurora Cannabis: Underappreciated Turnaround
Have Cannabis Investors Been Early Or Wrong Or Both?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$4.91 -0.26 (-5.03%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$4.89 -0.02 (-0.31%)
As of 09/3/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Cronos Group stock logo

Cronos Group NASDAQ:CRON

$2.53 +0.03 (+1.20%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$2.52 -0.01 (-0.59%)
As of 09/3/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Knight Therapeutics stock logo

Knight Therapeutics TSE:GUD

C$6.47 +0.02 (+0.31%)
As of 09/3/2025 05:40 PM Eastern

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

AXS Cannabis ETF stock logo

AXS Cannabis ETF NYSEARCA:THCX

$16.60 0.00 (0.00%)
As of 03/1/2024

The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments.